Lab-Grown Insulin-Producing Cells Restore Blood Sugar Control in Diabetic Mice
Similar Articles
Scientists Reverse Aging in Blood Stem Cells by Repairing Lysosomes
Preclinical Study Shows Hybrid Molecule Strategy May Improve Obesity and Diabetes Treatment
Modified CAR-T Cell Therapy Shows Promising HIV Suppression in Early Trial
Gene Therapy Trial Restores Hearing in Children Born Deaf
Scientists Identify Shared Regeneration Genes in Salamanders, Zebrafish, and Mice
Swedish scientists have developed a method to create insulin-producing cells from human stem cells. In a study, these lab-grown cells successfully restored the ability to regulate blood sugar when transplanted into diabetic mice, maintaining function for several months. This research represents a significant step toward a potential future cell therapy for Type 1 diabetes.
Facts First
- Human stem cells were engineered to produce insulin and respond to glucose levels in lab tests.
- Transplanted cells restored blood sugar regulation in diabetic mice for several months.
- Researchers refined the culture process to improve cell maturity and prevent unwanted cell types.
- The study was a collaboration between Karolinska Institutet and KTH Royal Institute of Technology.
- Funding came from multiple major foundations including the Swedish Research Council and the Novo Nordisk Foundation.
What Happened
Scientists from Karolinska Institutet and KTH Royal Institute of Technology developed a new method to generate insulin-producing cells from human stem cells. The research, published in the journal Stem Cell Reports, involved refining the cell culture process to allow the cells to form natural three-dimensional clusters, which addressed issues with cell maturity and the development of unwanted cell types. In laboratory tests, these lab-grown cells released insulin and responded to glucose levels. When transplanted into the anterior chamber of the eye of diabetic mice, the cells restored the animals' ability to regulate their own blood sugar, and this function was retained for several months following the transplant.
Why this Matters to You
For the millions of people living with Type 1 diabetes, where the immune system destroys the body's insulin-producing cells, this research could point toward a future treatment option beyond daily insulin injections. A successful cell therapy might one day restore the body's natural ability to manage blood sugar, which could significantly reduce the daily burden and long-term health risks associated with the disease. However, this is an early-stage study in mice, and translating the success to human patients will require years of further research and clinical trials.
What's Next
The research team will likely continue to refine the cell production method and conduct further animal studies. The next major hurdle will be testing the safety and efficacy of these lab-grown cells in human clinical trials, a process that could take many years. If successful, this approach could eventually lead to a new, potentially transformative therapy for Type 1 diabetes.